BIOMAT Database Logo BIOMAT Database Logo

Advanced colorectal cancer in elderly patients: tolerance and efficacy of leucovorin and fluorouracil bolus plus continuous infusion. 2001

R Mattioli, and P Lippe, and F Recchia, and C Massacesi, and L Imperatori, and S De Filippis, and M Rosselli, and P Gattafoni, and V Casadei, and D Consales
Medical Oncology Unit, S. Croce Hospital, I-61032 Fano, Italy.

BACKGROUND Colorectal cancer (CRC) incidence increases sharply with age. In this study we assessed activity, toxicity and both the activity of daily living (ADL) and instrumental activity of daily living (IADL) of the De Gramont schedule in a series of advanced CRC patients aged > or = 70 years. METHODS Sixty-two previously untreated advanced CRC patients entered the study. Median age was 75 (range 70-88). RESULTS 447 courses were delivered. All of the 62 patients were evaluable for toxicity, 55 for response and ADL-IADL indexes. We recorded 2 complete and 9 partial responses, for an overall response rate of 20%. ADL and IADL indexes improved in 33%, remained stable in 49% and worsened in 18% of evaluable patients. Treatment was very well-tolerated with no serious hematological or non-hematological toxicities. CONCLUSIONS The De Gramont schedule was very well tolerated in advanced CRC elderly patients, although our work could not confirm the original reported activity. ADL and IADL indexes improved or remained stable in 82% of evaluable patients.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D005240 Feasibility Studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. Feasibility Study,Studies, Feasibility,Study, Feasibility
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000203 Activities of Daily Living The performance of the basic activities of self care, such as dressing, ambulation, or eating. ADL,Chronic Limitation of Activity,Limitation of Activity, Chronic,Activities, Daily Living,Activity, Daily Living,Daily Living Activities,Daily Living Activity,Living Activities, Daily,Living Activity, Daily
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

R Mattioli, and P Lippe, and F Recchia, and C Massacesi, and L Imperatori, and S De Filippis, and M Rosselli, and P Gattafoni, and V Casadei, and D Consales
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.
February 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R Mattioli, and P Lippe, and F Recchia, and C Massacesi, and L Imperatori, and S De Filippis, and M Rosselli, and P Gattafoni, and V Casadei, and D Consales
Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.
February 1995, Cancer,
R Mattioli, and P Lippe, and F Recchia, and C Massacesi, and L Imperatori, and S De Filippis, and M Rosselli, and P Gattafoni, and V Casadei, and D Consales
Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer.
January 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R Mattioli, and P Lippe, and F Recchia, and C Massacesi, and L Imperatori, and S De Filippis, and M Rosselli, and P Gattafoni, and V Casadei, and D Consales
[Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].
September 2003, Nihon rinsho. Japanese journal of clinical medicine,
R Mattioli, and P Lippe, and F Recchia, and C Massacesi, and L Imperatori, and S De Filippis, and M Rosselli, and P Gattafoni, and V Casadei, and D Consales
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas.
June 2006, Annals of oncology : official journal of the European Society for Medical Oncology,
R Mattioli, and P Lippe, and F Recchia, and C Massacesi, and L Imperatori, and S De Filippis, and M Rosselli, and P Gattafoni, and V Casadei, and D Consales
[Continuous intraarterial infusion of 5-fluorouracil plus leucovorin for liver metastases from colorectal cancer].
February 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
R Mattioli, and P Lippe, and F Recchia, and C Massacesi, and L Imperatori, and S De Filippis, and M Rosselli, and P Gattafoni, and V Casadei, and D Consales
Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil.
January 1993, Cancer chemotherapy and pharmacology,
R Mattioli, and P Lippe, and F Recchia, and C Massacesi, and L Imperatori, and S De Filippis, and M Rosselli, and P Gattafoni, and V Casadei, and D Consales
Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
December 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R Mattioli, and P Lippe, and F Recchia, and C Massacesi, and L Imperatori, and S De Filippis, and M Rosselli, and P Gattafoni, and V Casadei, and D Consales
Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancer.
April 1992, Seminars in oncology,
R Mattioli, and P Lippe, and F Recchia, and C Massacesi, and L Imperatori, and S De Filippis, and M Rosselli, and P Gattafoni, and V Casadei, and D Consales
Biweekly bolus 5-fluorouracil and leucovorin plus oxaliplatin in pretreated patients with advanced colorectal cancer: a dose-finding study.
February 2003, Anti-cancer drugs,
Copied contents to your clipboard!